have been monitored. Rotaviruses are estimated to cause 125 million outpatient visits, 12 million hospitalizations, and 527,000 deaths (range, 475,000-580,000 deaths) annually among children aged !5 years; deaths occur predominately in low-income countries [1] . A safe and effective vaccine can avert these hospitalizations and deaths. Two new oral, live-attenuated rotavirus vaccines (Rotarix [GSK Biologicals] and RotaTeq [Merck] ) have been licensed in many countries worldwide. Both of the vaccines are safe and effective, preventing nearly all hospitalizations for rotavirus where they were tested in industrialized or middle-income countries [2, 3] . Efficacy and effectiveness studies of these vaccines are ongoing in Asia and Africa.
Rotashield (Wyeth-Lederle)-another oral rotavirus vaccine-was licensed in the United States in 1998 and was withdrawn in 1999 because of an increased risk of intussusception occurring shortly after its administration [4] . Epidemiological evidence supports a causal relationship between intussusception and the Rotashield vaccine, although the exact mechanism is not known [4] . An estimated population-attributable risk of 1 case of intussusception per 10,000 persons (range, 1 case in 5000-12,000 persons) has been reported [5] .
The risk appears to be greatest in the 3-7 days after the first dose of vaccine [6] .
Intussusception is the invagination of 1 segment of the intestine into its distal segment, resulting in obstruction of the bowel. Most intussusceptions are ileocolic. As an untreated condition, this may lead to death. Symptoms consistent with intussusception included severe colicky abdominal pain, persistent vomiting, bloody stools, abdominal bloating, and fever (body temperature, up to 41ЊC). The normal incidence in most developing countries is reported to be lower than that in industrialized countries; however, it is not clear whether this difference exists because of a decreased detection of cases or because of a different case definition [6] . Although baseline rates of idiopathic intussusception in the United States are estimated to be 50 cases per 100,000 children per year [7] , reliable rates from developing countries have been challenging to define.
We established surveillance of intussusception in preparation for trials of new rotavirus vaccines (before the Rotarix and RotaTeq vaccines were licensed and in anticipation of the development of additional vaccines), to ensure that intussusception cases would be identified and would be optimally managed, should they occur during trials. In addition, we anticipated that baseline intussusception rates would be helpful in providing a context during analyses of data from clinical trials of vaccines and during postmarketing effectiveness studies measuring the impact of rotavirus vaccines after their introduction and widespread use. The aim of this surveillance study was to estimate the background incidence of intussusception among children aged !2 years in a well-characterized, low-income population in rural Bangladesh. Matlab, a low-lying riverine area, is located 55 kilometers southeast of Dhaka, the capital of Bangladesh. Farming and fishing are the principal occupations of Matlab residents. Since 1966, a Health and Demographic Surveillance System (HDSS), which consists of regular cross-sectional censuses and longitudinal registration of vital events, has been maintained in the area [8] . A central treatment facility, staffed by physicians and paramedics, provides free treatment to 12,000-15,000 patients with diarrhea each year. A Maternal and Child Health-Family Planning Program has been in operation for one-half of the population of the HDSS area (current population of HDSS, ∼220,000 persons) since 1978, and intensive research has been conducted among this population. The other half of the population serves as a comparison area where regular government health care facilities are available. Each community health research worker in the intervention area covers a population of ∼1800 persons. The community health research workers visit each household monthly and are responsible for recording respiratory and diarrheal illnesses of children, vital events, immunizations of children, referrals of severely sick children and mothers, and other clinically relevant outcomes [9] .
METHODS

Study
The intussusception study was conducted in the whole Matlab HDSS area. The Matlab Hospital and 2 other treatment centers (in Nayergaon and Kalir bazar) of the ICDDR,B have been providing treatment for diarrhea to the people of the Matlab HDSS area and were among the primary catchment facilities for this study.
The average study population (aged !2 years) during the study period was 10,891 children per year. However, the incidence rates of probable and possible cases of intussusception were calculated on the basis of the number of children (midyear) who were aged !2 years in the specific year.
Recruitment and training. An expert ultrasonologist imparted 1 month of training on ultrasound examinations to a medical officer in Dhaka. The medical officer also provided training to the community health research workers on symptoms of intussusception based on the Brighton Collaboration criteria [10, 11] .
Retrospective surveillance. All medical records of hospitalized children aged !2 years at the Matlab Hospital and the community treatment centers at Nayergaon and Kalir bazar were reviewed for the period from January 2001 through August 2004, to identify patients who met the clinical case definition of intussusception as defined below by the Brighton Collaboration.
The Brighton Collaboration case definitions enable the assignment of probable or possible intussusception on the basis of clinical criteria-that is, without surgical or radiographic findings. Because radiographic or surgical confirmation was not systematically available for the retrospective survey, we relied on the Brighton Collaboration case definitions to assign cases of probable and possible intussusception.
On the basis of the current definitions, a probable case was defined by у2 of the following criteria (referred to by the Brighton Collaboration as "major criteria") [10, A possible case of intussusception was defined on the basis of the presence of 14 of the following "minor criteria" [10, 11] Royal Hospital, and Chandpur General Hospital), which serve the people of the Matlab area. The study medical officers visited these hospitals and clinics every 2 weeks. During their visits, they inquired with the medical officers of the respective hospital or clinic whether any patients aged !2 years from the Matlab HDSS area had presented with abdominal pain and distention, abdominal mass, bile-stained vomiting, and passage of stool containing "red currant jelly" material or blood. The study medical officers also checked the hospital registers for such cases. The medical officers of the government hospitals and clinics were also requested to inform the study medical officers about these cases via telephone. During routine monthly visits to all households, the community health research workers asked whether children aged !2 years had experienced the abovementioned symptoms consistent with intussusception. Children with any of these symptoms were referred to the Matlab Hospital for further assessment by physicians. Ultrasounds were performed for all these patients. The community health research workers also reminded and encouraged parents to bring their children to the Matlab Hospital if their children developed relevant symptoms. A referral and emergency transport system was established for patients with confirmed (by ultrasound) intussusception to be brought to the Dhaka Shishu Hospital (the country's largest pediatric hospital, with a surgeon experienced in management of intussusception). We present the results of the prospective surveillance for August 2004-December 2006. (Table 1 ). All possible cases occurred in boys, and ∼90% of patients with possible intussusception were aged !1 year. Ap- proximately 95% of the patients with possible intussusception were lethargic, and all presented with vomiting ( Table 2) . Prospective component. From August 2004 through December 2006, we evaluated 1508 children who were admitted to the Matlab Hospital and other treatment centers. Forty-one children aged !2 years with suspected intussusception were referred to the Matlab Hospital by the community health research workers for further evaluation by clinical and ultrasound examination, conducted by the medical officer. Of these 41 patients, only 2 met the definition of a probable case of intussusception set by the Brighton Collaboration criteria; neither case was confirmed by ultrasound examination. There was 1 possible case of intussusception (occurring in a male patient aged !1 year who had vomiting, lethargy, and hypovolumic shock) detected among the hospitalized patients. Ultrasound examinations were also done for 82 hospitalized patients who had some symptoms of intussusception: passing blood per the rectum and/or passing "red currant jelly" material along with vomiting and abdominal pain. Characteristics of the 2 patients with probable cases of intussusception are presented in Table  3 .
RESULTS
Retrospective
The annual population-based rates of probable and possible cases of intussusception were 0-17.8 and 17.7-81.7 cases per 100,000 children aged !2 years, respectively, in the retrospective surveillance (Table 4) . Only 2 probable cases and 1 possible case of intussusception were detected in the prospective surveillance, and the rates were 0-18.7 and 0-9.7 cases per 100,000 children aged !2 years, respectively.
DISCUSSION
We have documented rates of intussusception in a demographically defined rural area in Bangladesh. The results of our study revealed only 2 probable cases and 1 possible case of intussusception detected prospectively at the Matlab Hospital. The incidence rates of intussusception vary between countries. For example, rates were 65 cases per 100,000 children aged !1 year and 18 cases per 100,000 children aged 1-2 years in New Zealand [12] , 101 cases per 100,000 children aged !1 year in Australia [13] , 60 cases per 100,000 children in the first year of life in Singapore [14] , 78-100 cases per 100,000 children in Hong Kong [15] , and 32-35 cases per 100,000 children aged !2 years in Chile [16] . However, the variations among countries should be interpreted cautiously in the context of the ecological and methodological differences. The rates of probable cases we identified during the retrospective and prospective surveillance were lower than those that have been reported in these countries. However, with the very small numbers detected in this study, the possibility of error is large. Results of our study will be useful as part of an assessment of the safety of rotavirus vaccines, especially during postmarketing surveillance. On the basis of the low rates of intussusception detected, it should be relatively easy to observe an increase in intussusception rates after introduction of rotavirus vaccines in Bangladesh, if these vaccines were to trigger intussusception. The study procedures were useful in raising awareness about the potential for intussusception in the government hospitals and private clinics; awareness and surveillance of intussusception at these facilities continue. The study has several strengths. First, the study was conducted in an area where the ICDDR,B has been maintaining HDSS for 140 years and, as such, population-based rates of intussusception are available. Second, because the ICDDR,B is well known in the locality and all children within the HDSS area attend the Matlab Hospital and the community treatment centers, a retrospective surveillance is relatively sensitive. The community health research workers, who are based in the villages, visited all households monthly. Mothers were advised to bring their children to the Matlab Hospital for symptoms relating to intussusception. The community health research workers also referred many cases to the Matlab Hospital.
We identified 4 probable cases in the retrospective surveillance, which covered 44 months, and 2 probable cases in the prospective surveillance, which covered 29 months; thus, the rates were similar. We found 19 possible cases in the retrospective surveillance and only 1 in the prospective surveillance. The reasons for this difference are not clear, because the diagnostic criteria remained the same during the 2 periods of surveillance.
We did not find any cases of intussusception with level 1 diagnostic certainty (confirmation by surgical or radiological criteria or by autopsy) [10, 11] . Most patients with probable or possible cases of intussusception presented with symptoms of vomiting. These cases are similar to those reported earlier [11, 16] . The predominance of male patients among those with possible and probable cases in our study is consistent with results of previous studies [17] . There were no deaths in our study, and all cases were conservatively managed at the Matlab Hospital. This suggests that these cases were referred at an early stage of illness.
Although it is hoped that the currently available rotavirus vaccines will not be associated with intussusception, the possibility cannot be ruled out, because the physiological basis of the association of intussusception with Rotashield has not yet been defined. These background rates of intussusception will be helpful to evaluate any association between vaccination and intussusception in the currently ongoing RotaTeq efficacy study and Rotarix effectiveness study and any future studies in Matlab. The rates will also be useful for the calculation of sample size and for communication about the study to the general public and parents who need to understand the risks and the potential for coincidental intussusception that may occur during a vaccine trial.
Bangladesh is a low-income country without a national vaccine adverse event reporting system. Bangladesh and other lowincome countries depend on the pooled experience of the international scientific community to assess vaccine safety and efficacy. Although the statistical power to assess infrequent adverse events of low attributable risk is limited at any single site, this study illustrates that active surveillance of important adverse outcomes is feasible and, thus, can contribute important safety data from a setting in which the vaccine is expected to have a substantial public health impact.
